(Q35758967)

10 August 2017

title

Population pharmacokinetic model for gatifloxacin in pediatric patients (English)

1 reference

10 August 2017

1 reference

4

Jeffrey L Blumer

1 reference

10 August 2017

5

Gregory L Kearns

1 reference

10 August 2017

2

Edmund V Capparelli

1 reference

10 August 2017

Christopher M Rubino

1

1 reference

10 August 2017

John S Bradley

3

1 reference

10 August 2017

Michael Reed

6

1 reference

10 August 2017

Richard F Jacobs

7

1 reference

10 August 2017

Brenda Cirincione

8

1 reference

10 August 2017

Dennis M Grasela

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

12 January 2007

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

51

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

1246-1252

1 reference

Pharmacokinetics of gatifloxacin in infants and children

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Clinical pharmacodynamics of quinolones

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Predicting efficacy of antiinfectives with pharmacodynamics and Monte Carlo simulation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study Team

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Clinical pharmacology of gatifloxacin, a new fluoroquinolone

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

The use of population pharmacokinetics in drug development

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Estimation of human body surface area from height and weight

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

Methodological issues in pharmacokinetic-pharmacodynamic modelling.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855513

A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17220409

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17220409

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17220409

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00685-06

1 reference

10 August 2017

1 reference

10 August 2017

1 reference